Clinical Trials List
2021-12-01 - 2022-12-12
Phase II
Recruiting6
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
COVANCE TAIWAN SERVICES LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yao-Lung Kuo 無
- Chun-Hui Lee 無
- 楊舜如 無
- Jui-Hung Tsai 無
- Kuo-Ting Lee 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Huey-En Tzeng 無
- ZHENG-WEI ZHOU 無
- 王國鐘 無
- 陳維信 無
- Kuan-Der Lee 無
- I-Chen Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chung Chao 無
- Jiun-I Lai 無
- Chun-Yu Liu 無
- 林燕淑 無
- 邱仁輝 無
- 賴亦貞 無
- Chi-Cheng Huang 無
- Yi-Fang Tsai 無
- 馮晉榮 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林季宏 無
- 黃柏翔 無
- 林柏翰 無
- 張端瑩 無
- WEI-LI MA 無
- 朱筱桑 無
- Wei-Wu Chen 無
- MING-YANG WANG 無
- 陳怡君 無
- 羅喬 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
210 participants
